Evidence map›Paper›PMID 30755424›Full record

ArticleBMJ case reports2019

Hydrochlorothizide-induced acute generalised exanthematous pustulosis presenting with bilateral periorbital impetigo.

Leo E Reap, Cassandra Rodd, Jose Larios, Michael Marshall

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Estradiol Valerate Tablets Caused Rare Severe Drug Eruption: The First Reported Case.Clinical, cosmetic and investigational dermatology · 2024
    Article
  2. Article
  3. Article
  4. Review
  5. Current Perspectives on Severe Drug Eruption.Clinical reviews in allergy & immunology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Leo E ReapInternal Medicine, Ascension Providence Hospital, Southfield, Michigan, USA.ORCID http://orcid.org/0000-0002-7421-2765
Cassandra RoddMichigan State University College of Human Medicine, East Lansing, Michigan, USA.
Jose LariosAscension Providence Hospital, Southfield, Michigan, USA.
Michael MarshallAscension Providence Hospital, Southfield, Michigan, USA.
Ascension Providence Hospital · USAscension · USMichigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute generalised exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction characterised by the appearance of erythematous plaques and papules with overlying non-follicular pinpoint pustules. Drugs are the cause of AGEP in approximately 90% of cases. The most common causes include anti-infective agents (aminopenicillins, quinolones, antibacterial sulfonamides and terbinafine), antimalarials and diltiazem. To the best of our knowledge, to date there has only been one report of hydrochlorothiazide-induced AGEP. There has never been a case report of losartan-induced AGEP. Here, we present a case of AGEP that is the second case purportedly caused by hydrochlorothiazide.

Indexed as

Acute Generalized Exanthematous PustulosisAdministration, TopicalAged, 80 and overAnti-Infective AgentsBetamethasoneDrug-Related Side Effects and Adverse ReactionsEye DiseasesFemaleGlucocorticoidsHumansHydrochlorothiazideImpetigoMetoprololTreatment OutcomeAnti-Infective AgentsBetamethasoneGlucocorticoidsHydrochlorothiazideMetoprololcardiovascular systemdermatologydrug interactions unwanted effects / adverse reactionsdrugs and medicines

Identifiers

PMID30755424
PMCPMC6381958
OpenAlexW2913759616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.